GB1603281A - Derivatives of 9-fluoroprednisolone - Google Patents

Derivatives of 9-fluoroprednisolone Download PDF

Info

Publication number
GB1603281A
GB1603281A GB10925/78A GB1092578A GB1603281A GB 1603281 A GB1603281 A GB 1603281A GB 10925/78 A GB10925/78 A GB 10925/78A GB 1092578 A GB1092578 A GB 1092578A GB 1603281 A GB1603281 A GB 1603281A
Authority
GB
United Kingdom
Prior art keywords
pregnadiene
hydroxy
fluoro
dione
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10925/78A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2712862A external-priority patent/DE2712862C2/de
Priority claimed from DE19782809732 external-priority patent/DE2809732C2/de
Application filed by Schering AG filed Critical Schering AG
Publication of GB1603281A publication Critical patent/GB1603281A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB10925/78A 1977-03-21 1978-03-20 Derivatives of 9-fluoroprednisolone Expired GB1603281A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2712862A DE2712862C2 (de) 1977-03-21 1977-03-21 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE19782809732 DE2809732C2 (de) 1978-03-03 1978-03-03 Derivate des 9-Fluorprednisolons, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate, die diese Wirkstoffe enthalten

Publications (1)

Publication Number Publication Date
GB1603281A true GB1603281A (en) 1981-11-25

Family

ID=25771793

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10925/78A Expired GB1603281A (en) 1977-03-21 1978-03-20 Derivatives of 9-fluoroprednisolone

Country Status (20)

Country Link
JP (1) JPS53130651A (it)
AT (1) AT365203B (it)
AU (1) AU525614B2 (it)
CA (1) CA1104124A (it)
CH (1) CH638226A5 (it)
CS (1) CS202591B2 (it)
DD (1) DD134955A5 (it)
DK (1) DK126378A (it)
ES (1) ES468107A1 (it)
FR (1) FR2384792A1 (it)
GB (1) GB1603281A (it)
GR (1) GR70385B (it)
IE (1) IE46584B1 (it)
IL (1) IL54308A (it)
IT (1) IT1095477B (it)
LU (1) LU79271A1 (it)
NO (1) NO151043C (it)
NZ (1) NZ186735A (it)
RO (1) RO81525B (it)
SE (1) SE431656B (it)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853785A1 (de) * 1978-12-11 1980-06-19 Schering Ag Neue prednison-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische praeparate und deren verwendung
JPH07116215B2 (ja) * 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
JPH07213320A (ja) * 1994-02-04 1995-08-15 Daiwa:Kk 長尺物用バック

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2055221A1 (en) * 1970-11-10 1972-05-18 Laboratorio Chimico Farmaceutico Dr. P. Blasina S.R.L., Mailand (Italien) 17-acyloxy-3-keto-pregn-4-enes prepn - by acylating 17-hydroxy steroids in presence ofstannic chloride
CH529739A (fr) * 1972-02-28 1972-10-31 Sdc Steroidi Dev Co Procédé pour la préparation d'un stéroïde de la série des prégnadiènes
US3832366A (en) * 1973-07-30 1974-08-27 Squibb & Sons Inc Process for preparing 21-chloro-17-acyloxy-20-ketosteroids

Also Published As

Publication number Publication date
IE780545L (en) 1978-09-21
NO151043B (no) 1984-10-22
IL54308A0 (en) 1978-06-15
JPS6131116B2 (it) 1986-07-17
LU79271A1 (de) 1978-06-29
NZ186735A (en) 1980-10-24
NO780984L (no) 1978-09-22
SE431656B (sv) 1984-02-20
ATA195978A (de) 1981-05-15
DD134955A5 (de) 1979-04-04
DK126378A (da) 1978-09-22
IL54308A (en) 1984-03-30
SE7803168L (sv) 1978-09-22
IE46584B1 (en) 1983-07-27
ES468107A1 (es) 1979-07-01
AU3434678A (en) 1979-09-27
CA1104124A (en) 1981-06-30
AU525614B2 (en) 1982-11-18
CH638226A5 (en) 1983-09-15
RO81525B (ro) 1983-04-30
FR2384792A1 (fr) 1978-10-20
IT7821364A0 (it) 1978-03-20
JPS53130651A (en) 1978-11-14
NO151043C (no) 1985-01-30
AT365203B (de) 1981-12-28
GR70385B (it) 1982-10-05
RO81525A (ro) 1983-04-29
CS202591B2 (en) 1981-01-30
FR2384792B1 (it) 1980-04-04
IT1095477B (it) 1985-08-10

Similar Documents

Publication Publication Date Title
KR890000761B1 (ko) 스테로이드의 방향성 헤테로사이클릭 에스테르 및 이의 제조방법
US4267173A (en) Use of 6β-fluoro-7α-halogenocorticoids as topical anti-inflammatories and pharmaceutical formulations useful therefor
JPH0149278B2 (it)
EP0072546B1 (de) Neue Hydrocortison-Derivate, ihre Herstellung und Verwendung
IE56281B1 (en) Novel 6alpha-methylcorticoins and their manufacture and use
US4777165A (en) 6α, 16β-dimethyl corticoids and their anti-inflammatory use
US4176126A (en) Novel corticoids
CA1251784A (en) Steroids esterified in position 17 and thioesterified in position 21, a process for preparing them and their use as medicaments
GB1603281A (en) Derivatives of 9-fluoroprednisolone
GB2089808A (en) 5 alpha - and 5 beta -androstane-17 beta - carboxylates and -thiocarboxylates
GB1594852A (en) Derivatives of 9-chloroprednisolone
JPH0257559B2 (it)
US4207316A (en) Novel 17-substituted 11 β-hydroxy steroids of the pregnane series, their manufacture, preparation and use
CA1100943A (en) Derivatives of 9-chloroprednisolone
US4185101A (en) 1,3,5(10),6,8-19-Nor-pregnapentaenes, their use as anti-psoriatic agents, and pharmaceutical formulations useful therefor
IE45305B1 (en) New corticoids
EP0000609B1 (en) Novel 19-nor-pregnahexaenes, process for the preparation thereof, and pharmaceutical compositions containing them
JPS6361000B2 (it)
KR840000154B1 (ko) 신규 6α-플루오로-프레드니솔론 17, 21-디에스테르의 제조방법
HU181970B (en) Process for preparing new derivatives of 9alpha-fluoro-prednisolone
DE2809732A1 (de) Neue derivate des 9-fluorprednisolons
CS199512B2 (cs) Způsob výroby kortikoidfi
CS207756B2 (cs) Způsob výroby v poloze 17 substituovaných 11β-bydroxysteroidů pregnanové řady
CS202593B2 (cs) Způsob výroby derivátů 9-fluorprednisolonu
CS244663B2 (cs) Způsob výroby nových derivátů 9-chlorprednisolonu

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee